Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double-Masked, Randomized, Vehicle-controlled Trial Evaluating the Efficacy and Safety of Cevimeline Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease

NCT06543303 is registered in ClinicalTrials.gov with BioTheraVision, Inc. as lead sponsor.

NCT NCT06543303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06543303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double-Masked, Randomized, Vehicle-controlled Trial Evaluating the Efficacy and Safety of Cevimeline Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease
Lead sponsor
BioTheraVision, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2024
Completion date
January 14, 2026
Enrollment
123 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye